{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:30:45Z","timestamp":1759336245312},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/wnf.0b013e318280028a","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T22:04:40Z","timestamp":1363989880000},"page":"68-69","source":"Crossref","is-referenced-by-count":4,"title":["Blonanserin, an Antipsychotic and Dopamine D2\/D3 Receptor Antagonist, and Ameliorated Alcohol Dependence"],"prefix":"10.1097","volume":"36","author":[{"given":"Manabu","family":"Takaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ujike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210203","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2165\/00023210-200923070-00006","article-title":". The efficacy and safety of blonanserin compared with haloperidol in acute-phase schizophrenia: a randomized, double-blind, placebo-controlled, multicentre study.","volume":"23","author":"Garcia","year":"2009","journal-title":"CNS Drugs"},{"key":"R2-9-20210203","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/WNF.0b013e3181dcda50","article-title":". Efficacy and tolerability of blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.","volume":"33","author":"Yang","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"R3-9-20210203","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/11202620-000000000-00000","article-title":"Blonanserin: a review of its use in the management of schizophrenia.","volume":"24","author":"Deeks","year":"2010","journal-title":"CNS Drugs"},{"key":"R4-9-20210203","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1601-5215.2012.00663.x","article-title":". Efficacy and tolerability of blonanserin in 48 patients with intractable schizophrenia.","volume":"24","author":"Takaki","year":"2012","journal-title":"Acta Neuropsychiatrica"},{"key":"R5-9-20210203","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bcp.2007.08.005","article-title":"Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.","volume":"75","author":"Johnson","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"R6-9-20210203","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1369-1600.2007.00051.x","article-title":". Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice.","volume":"12","author":"Heidbreder","year":"2007","journal-title":"Addict Biol"},{"key":"R7-9-20210203","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1096\/fj.06-6110com","article-title":". The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse.","volume":"20","author":"Vengeliene","year":"2006","journal-title":"FASEB J"},{"key":"R8-9-20210203","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1017\/S1461145706007164","article-title":". The efficacy of the dopamine D2D3 antagonist tiapride in maintaining abstinence: a randomized, double-blind, placebo-controlled trial in 299 alcohol-dependent patients.","volume":"10","author":"Bender","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"R9-9-20210203","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S1359-6446(05)03491-4","article-title":"Dopamine D3 receptor antagonists as therapeutic agents.","volume":"10","author":"Joyce","year":"2005","journal-title":"Drug Discov Today"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0b013e318280028a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:15:14Z","timestamp":1620976514000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201303000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e318280028a","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}